Orion OYJ Unsponsored ADR (OTCMKTS:ORINY - Get Free Report)'s share price reached a new 52-week high during trading on Friday . The stock traded as high as $37.53 and last traded at $37.53, with a volume of 136 shares changing hands. The stock had previously closed at $35.45.
Orion OYJ Price Performance
The company has a debt-to-equity ratio of 0.27, a current ratio of 3.79 and a quick ratio of 2.27. The business's 50-day moving average price is $32.43 and its two-hundred day moving average price is $28.47. The firm has a market cap of $10.59 billion, a price-to-earnings ratio of 28.65 and a beta of 0.07.
Orion OYJ (OTCMKTS:ORINY - Get Free Report) last announced its quarterly earnings data on Wednesday, April 23rd. The company reported $0.23 earnings per share (EPS) for the quarter. Orion OYJ had a return on equity of 36.23% and a net margin of 21.74%. The firm had revenue of $373.03 million for the quarter. On average, research analysts forecast that Orion OYJ Unsponsored ADR will post 1.18 EPS for the current fiscal year.
About Orion OYJ
(
Get Free Report)
Orion Oyj develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally. The company provides prescription drugs and self-care products, which includes Nubeqa for the treatment of prostate cancer; Precedex, Dexdor, and Precedex for human use; Burana for inflammatory pain; Divina series for menopausal symptoms; Trexan for rheumatoid arthritis and cancer; Stalevo, Entacapone, and Comtess/Comtan for Parkinson's disease; Biosimilars for rheumatoid arthritis and inflammatory bowel diseases; and Simdax for acute decompensated heart failure, as well as Fareston for breast cancer.
Featured Articles
Before you consider Orion OYJ, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Orion OYJ wasn't on the list.
While Orion OYJ currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
